[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"cookie-copy":3,"important-message":10,"mainMenu":23,"onboarding":24,"contribution-page-SE-0-SE-6-54100039":199,"footer":863},{"content":4,"modalContent":7},{"en":5,"sv":6},"\u003Cp>Openaid.se uses cookies to improve your experience as a user, including cookies for web analytics and cookies that help the website function properly. Cookies that handle your selection in this box cannot be opted out. \u003Ca href=\"https:\u002F\u002Fopenaid.se\u002Fen\u002Fabout-openaid\u002Fabout-the-website\">Read more about cookies at Openaid.se\u003C\u002Fa>\u003C\u002Fp>\n","\u003Cp>Openaid.se använder kakor för att förbättra upplevelsen för dig som användare, bland annat kakor för webbanalys och kakor som bidrar till att webbplatsen fungerar korrekt. Kakor som hanterar ditt val i denna ruta går inte att välja bort. \u003Ca href=\"https:\u002F\u002Fopenaid.se\u002Fabout-openaid\u002Fabout-the-website\">Läs mer om kakor på Openaid.se\u003C\u002Fa>\u003C\u002Fp>\n",{"en":8,"sv":9},"\u003Cp>Openaid.se use necessary and functional cookies to make our website work. We also use cookies to improve website functionality by obtaining statistics on how the site is used. You can change your settings here at any time. \u003Ca href=\"https:\u002F\u002Fopenaid.se\u002Fen\u002Fabout-openaid\u002Fabout-the-website\">Read more\u003C\u002Fa>\u003C\u002Fp>\n","\u003Cp>Här godkänner du vilka kakor webbplatsen får spara i din dator. Du kan när som helst ändra dina inställningar. \u003Ca href=\"https:\u002F\u002Fopenaid.se\u002Fabout-openaid\u002Fabout-the-website\">Läs mer om kakor på Openaid.se\u003C\u002Fa>\u003C\u002Fp>\n",{"data":11,"show":12},{"active":12,"title":13,"message":16,"link":19,"link_text":21,"starttime":22,"endtime":20},false,{"en":14,"sv":15},"The website is currently experiencing technical issues ","Tekniska problem",{"en":17,"sv":18},"We are currently experiencing technical issues and are working to restore the website as soon as possible. Please try again later.\r\n\r\nContact openaid@sida.se for more information.","Vi har just nu tekniska problem och arbetar med att återställa webbplatsen. Försök gärna igen senare.\r\n\r\nKontakta openaid@sida.se vid frågor.\r\n",{"en":20,"sv":20},"",{"en":20,"sv":20},"2026-08-18T10:41:32",{},{"help":25,"intro":73,"tour":128},{"data":26,"enabled":72},{"page_description":27,"tour_description":52,"intro_description":62},[28,34,40,46],{"page":29,"description":31},{"en":30,"sv":30},"%2Ffind-aid%2Fsector-category",{"en":32,"sv":33},"On this page sector categories are listed and can be filtered by year or search keyword.","På den här sidan listas sektorkategorier, som beskriver vilket specifikt område hos en mottagare som en aktivitet ska gynna och utveckla. Dessa kan filtreras på år och sökord.",{"page":35,"description":37},{"en":36,"sv":36},"%2Ffind-aid%2Fdonors",{"en":38,"sv":39},"On this page responsible government agencies are listed and can be filtered by year or search keyword.","På den här sidan listas ansvariga myndigheter. Dessa kan filtreras på år och sökord.",{"page":41,"description":43},{"en":42,"sv":42},"%2Ffind-aid%2Fcountries-and-regions",{"en":44,"sv":45},"On this page countries and regions are listed.","På den här sidan listas länder och regioner där Sverige bedriver utvecklingssamarbete och där stöd ska bidra till utvecklingsresultat.",{"page":47,"description":49},{"en":48,"sv":48},"%2Ffind-aid%2Fpartners",{"en":50,"sv":51},"Choose a partner that Swedish government agencies cooperate with to implement Swedish aid.","På den här sidan listas samarbetspartner som ansvariga myndigheter samarbetar med för att genomföra biståndet.",{"title":53,"description":56,"button_text":59},{"en":54,"sv":55},"Do you need help?","Vill du ha hjälp att utforska biståndet?",{"en":57,"sv":58},"Join a tour and get tips on what to do on this page.","Följ med på en rundtur med tips på vad du kan göra på denna sida.",{"en":60,"sv":61},"Start the tour","Visa mig runt på sidan",{"title":63,"description":66,"button_text":69},{"en":64,"sv":65},"Do you want to know more about Openaid?","Vill du veta mer om Openaid?",{"en":67,"sv":68},"Here you will get a quick introduction to Openaid and what you can do on this website.","Här får du en snabb introduktion till vad Openaid är och vad du kan göra på webbplatsen.",{"en":70,"sv":71},"Start introduction","Starta introduktionen",true,{"data":74,"enabled":72},[75,83,91,101,111,120],{"title":76,"description":79,"other_info":82},{"en":77,"sv":78},"Welcome to Openaid","Välkommen till Openaid",{"en":80,"sv":81},"Here you will find information about when, to whom and for what purpose Swedish aid funds have been disbursed since 1998. You can also see the results that have been achieved. ","Här kan du se när, till vem och för vilket ändamål svenskt statligt bistånd har betalats ut sedan 1998. Du kan också se biståndets resultat. ",{"en":20,"sv":20},{"title":84,"description":87,"other_info":90},{"en":85,"sv":86},"Openaid shows data from different agencies","Openaid visar data från olika myndigheter",{"en":88,"sv":89},"Statistics and payments from all Swedish government agencies handling funds in the Expenditure area 7: International aid form the basis for the data presented on Openaid.","På Openaid kan du hitta statistik och utbetalningar från alla myndigheter och departement som hanterar statliga biståndsmedel.",{"en":20,"sv":20},{"title":92,"description":95,"other_info":98},{"en":93,"sv":94},"Choose what data you want to see","Välj vilken data du vill se",{"en":96,"sv":97},"You can choose to see data from specific agencies, to specific countries or regions or within specific sectors. You can also see contributions performed by a specific partner.","Du kan välja att se data från vissa myndigheter, till vissa geografiska områden eller inom vissa sektorkategorier, som beskriver vilket temaområde en insats genomförs i. Du kan också se insatser som utförts av en viss samarbetspartner.",{"en":99,"sv":100},"Openaid is continuously updated. This means that for the current and previous year, sums are updated as data is reported and published. ","Openaid uppdateras löpande. Det innebär att för nuvarande år och föregående år uppdateras summor i takt med att data rapporteras in och publiceras. ",{"title":102,"description":105,"other_info":108},{"en":103,"sv":104},"See contributions","Se enskilda biståndsinsatser",{"en":106,"sv":107},"You can get in-depth information about a contribution. Here you can see results, transactions and documents. ","Du kan få fördjupad information om en enskild insats som gjorts inom biståndet. Här kan du se resultat, transaktioner och dokument. ",{"en":109,"sv":110},"The website’s data can be exported. ","All data på Openaid går att exportera. ",{"title":112,"description":114,"other_info":117},{"en":54,"sv":113},"Hjälpen är alltid nära",{"en":115,"sv":116},"Locate the button with a question mark in the lower right corner!","På Openaid finns fler tips på vad du kan göra. Leta upp knappen med frågetecknet i högra hörnet!",{"en":118,"sv":119},"For questions, please contact openaid@sida.se.","Vid frågor, kontakta openaid@sida.se.",{"title":121,"description":124,"other_info":127},{"en":122,"sv":123},"Explore aid","Är du redo att utforska biståndet?",{"en":125,"sv":126},"Start exploring the Swedish development cooperation on Openaid. Either on your own or by joining the tour.","Nu kan du börja utforska biståndet på Openaid – antingen på egen hand eller genom att följa med på en rundtur.",{"en":20,"sv":20},{"data":129,"enabled":72},{"general":130,"startpage":150,"explore_aid":165},[131,141],{"id":132,"title":133,"description":136,"other_info":139},"explore-aid-menu-button",{"en":134,"sv":135},"Find all Swedish aid","Hitta till allt bistånd",{"en":137,"sv":138},"Here you can find data based on responsible agencies, countries and regions, partners, sector categories, strategies and The Sustainable Development Goals. ","Här kan du hitta bistånd utifrån ansvarig myndighet, länder och regioner, samarbetspartner, sektorkategorier, strategier och Globala målen. ",{"en":140,"sv":140},null,{"id":142,"title":143,"description":146,"other_info":149},"main-search",{"en":144,"sv":145},"Search the site","Sök på webbplatsen",{"en":147,"sv":148},"Here you can search for any content on the site, for example a country, a contribution or a document.","Här kan du söka på allt innehåll efter till exempel ett land, en insats eller ett dokument.",{"en":140,"sv":140},[151,160],{"id":152,"title":153,"description":156,"other_info":159},"show-aid-button",{"en":154,"sv":155},"Explore aid on your own","Utforska biståndet på egen hand",{"en":157,"sv":158},"You can choose which responsible agencies you want to see Swedish aid from, to which geographical areas and within which sector categories.","Du kan välja vilka ansvariga myndigheter du vill se bistånd från, till vilka geografiska områden samt inom vilka sektorkategorier. ",{"en":140,"sv":140},{"id":161,"title":162,"description":163,"other_info":164},"more-choices-filter-button",{"en":20,"sv":20},{"en":20,"sv":20},{"en":140,"sv":140},[166,171,176,181,190],{"id":167,"title":168,"description":169,"other_info":170},"comparison-filter-card",{"en":20,"sv":20},{"en":20,"sv":20},{"en":140,"sv":140},{"id":172,"title":173,"description":174,"other_info":175},"comparison-filter-modal-trigger",{"en":20,"sv":20},{"en":20,"sv":20},{"en":140,"sv":140},{"id":177,"title":178,"description":179,"other_info":180},"add-comparison-button",{"en":20,"sv":20},{"en":20,"sv":20},{"en":140,"sv":140},{"id":182,"title":183,"description":186,"other_info":189},"compare-explore-aid-navigation",{"en":184,"sv":185},"See how the aid is distributed","Se hur biståndet är fördelat",{"en":187,"sv":188},"Here you can see how the Swedish aid has been distributed based on your filter options.","Här kan du snabbt navigera och se hur biståndet har fördelats utifrån de val du har gjort.",{"en":140,"sv":140},{"id":191,"title":192,"description":195,"other_info":198},"export-button",{"en":193,"sv":194},"Export data","Exportera data",{"en":196,"sv":197},"You can export the data in xls-format.","Här kan kan du exportera data i xls-format.",{"en":140,"sv":140},{"contribution":200,"activities":415,"paidTransactions":838,"transactions":859,"strategies":862},{"iatiidentifier":201,"reportingorg":202,"title":207,"descriptions":212,"participatingorgs":225,"activitystatus":232,"activitydates":233,"defaultflowtype":239,"contactinfo":240,"recipientregions":247,"sectors":252,"documentlinks":259,"result":321,"relatedactivities":336,"lastupdateddatetime":339,"lang":340,"defaultcurrency":341,"hierarchy":219,"humanitarianSpecified":12,"hasHumanitarianActivity":12,"hasLongtermActivity":72,"transactionsMetadata":342,"activitiesMetadata":410},"SE-0-SE-6-54100039",{"narrative":203,"ref":204,"type":205,"secondaryreporter":206},"Sweden","SE-0",10,0,[208,211],{"lang":209,"value":210},"sv","EDCTP2: European & Dev. Countries Clinical Trials Partnership 2015 - 2026",{"value":210},[213,220],{"narrative":214,"type":219},[215,217],{"value":216},"Support to European and Developing Countries Clinical Trials          Partnership to accelerate development of new or improved druugs ,     vaccines, microbicides and diagnostics against HIV\u002FAIDS; TB and       malaria. Support provided since 2004. A new expanded programme is     planned within Horizon2020 which will be called EDCTP2.",{"lang":209,"value":218},"BAKGRUND \nPartnerskapet mellan Europa och utvecklingsländer inom området klinisk prövning (EDCTP) inrättades 2003 för att hantera den globala hälsokris som orsakas av de tre största fattigdomsrelaterade sjukdomarna hiv\u002Faids, malaria och tuberkulos och för att fullgöra EU:s åtagande att uppnå FN:s millennieutvecklingsmål till 2015. Sverige har genom Sida bidragit med biståndsmedel till EDCTP och Sida har i enlighet med regeringens beslut den 23 oktober 2003 (UD2003\u002F 53044\u002F GU) företrätt Sverige inom EDCTP:s första program.\n\nFör genomförandet av EDCTP2 har en stiftelse med säte i Haag, Nederländerna, bildats. Medverkande stater ska utse en myndighet\u002F institution som företrädare och medlem i stiftelsen.\n\nErfarenheterna av svensk medverkan under partnerskapets första program är mycket goda. Regeringen anser att Sveriges engagemang i EDCTP ska fortsätta under det andra programmet, och har erhållit riksdagens bemyndigande att besluta om deltagande i den stiftelse som inrättats som genomförandestruktur för EDCTP2 (prop. 2014\u002F15:1 utg.omr. 7, bet. 2014\u002F 15:UU2, rskr. 2014\u002F15:75). Enligt regeringens beslut ska \"finansiering av det svenska deltagandet sker genom medel som Sida disponerar inom ramen för utgiftsområde 7, anslag 1:1 Biståndsverksamhet\".\n\nRegeringen har beslutat (Regeringsbeslut UF2015\u002F 12547\u002FUD\u002FUSTYR) att Sverige ska delta och har uppdragit åt Sida att företräda Sverige i den stiftelse som bildats som genomförandestruktur (EDCTP2- IS) för det andra programmet för partnerskap mellan Europa och Afrika inom området kliniskprövning (EDCTP2).\n\nProgrammet är 10 år, men Sidas beslut handlar enbart om medelstilldelning för kommande femårsperiod av EDCTP2 programmet.\n\nI tillägg till Sidas bidrag ska Sverige räkna in alla offentliga medel som går till forskning inom EDCTP2 fokusområden som del av det totala bidraget. Det inkluderar Sidas bidrag inom globala och bilaterala samarbeten samt Vetenskapsrådets och andra relevanta svenska myndigheters bidrag till forskning inom EDCTP2 fokusområden. \n\nUPPDRAGET \nEDCTP syftar till att stödja forskningssamarbete som accelererar den kliniska utvecklingen av nya eller förbättrade interventioner för att förebygga eller behandla HIV\u002FAIDS, tuberkulos, malaria och andra försummade infektionssjukdomar i Afrika söder om Sahara.\n  \nPROGRAMMET \nDet andra EDCTP-programmet (EDCTP2) genomförs som en del av det europeiska ramprogrammet för forskning och Innovation, ”Horizon 2020”.  Europeiska unionens bidrag till EDCTP kan uppgå till 683 miljoner euro för det 10-åriga programmet (2014-2024), förutsatt att detta motsvaras av bidrag från de deltagande europeiska staterna.  \n\nDELTAGANDE \nDe länder som deltar i EDCTP2 som medlemmar i föreningen EDCTP i oktober 2015 är: 14 europeiska länder-Österrike, Danmark, Finland, Frankrike, Tyskland, Irland, Italien, Luxemburg, Nederländerna, Norge, Portugal, Spanien, Sverige, UK; och 14 afrikanska länder – Burkina Faso, Kamerun, Kongo, Gabon, Gambia, Ghana, Mali, Moçambique, Niger, Senegal, Sydafrika, Tanzania, Uganda och Zambia. Flera länder kan komma att ansluta.\n\nSTYRELSEFORMER \nEDCTP stiftelsen kommer att genomföra EDCTP2-programmet. Stiftelsen styrs av sina medlemmar, de deltagande europeiska och afrikanska staterna, genom generalförsamlingen. Sekretariatet utför verksamheten inom programmet. Det främsta vetenskaplig rådgivande organ till generalförsamlingen och sekretariatet är den rådgivande vetenskaplig kommitté (Scientific Advisory Committee).",1,{"narrative":221,"type":224},[222],{"value":223},"To accelerate research and development of new or improved diagnostics, drugs, microbicides and vaccines against HIV\u002FAIDS, tuberculosis, malaria and NIDs.\n",2,[226,228],{"narrative":203,"ref":204,"crsChannelCode":227,"type":205,"typeSpecified":72,"role":219},"11001",{"narrative":229,"ref":230,"crsChannelCode":227,"type":205,"typeSpecified":72,"role":231},"Swedish International Development Cooperation Agency","SE-6",3,{"code":224},[234,236,238],{"type":224,"isodate":235},"2015-12-01T00:00:00",{"type":231,"isodate":237},"2027-12-31T00:00:00",{"type":219,"isodate":235},{"code":205},{"organisation":241,"telephone":242,"email":243,"website":244,"mailingaddress":245},{"narrative":229},"+46 8 698 50 00","sida@sida.se","www.sida.se",{"narrative":246},"Box 2025, 174 02 Sundbyberg, Sweden",[248],{"narrative":249,"code":250,"percentage":251},"Africa, regional","298",100,[253,256],{"narrative":254,"code":255,"vocabulary":219,"percentage":251},"Medical research",12182,{"narrative":257,"code":258,"vocabulary":224,"percentage":251},"Health, General",121,[260,268,275,281,287,293,299,304,310,315],{"title":261,"category":264,"url":266,"format":267},{"narrative":262},{"lang":209,"value":263},"Beslut om ändring av insats European and Developing Countries Clinical Trials Partnership 2 (EDCTP2) 2021",{"code":265},"A05","https:\u002F\u002Fdocuments.iati.openaid.se\u002Fdocument\u002Fforsk\u002F54100039_011501-21BeslutomandringavinsatsEDCTP2-Europeananddevelopmentcountriesclinical2897506_1_1.pdf","application\u002Fpdf",{"title":269,"category":272,"url":274,"format":267},{"narrative":270},{"lang":209,"value":271},"Ändring avtal insats European and Developing Countries Clinical Trials Partnership 2 (EDCTP2) 2021",{"code":273},"A04","https:\u002F\u002Fdocuments.iati.openaid.se\u002Fdocument\u002Fforsk\u002F54100039_013221-21AmendmenttotheAgreementontheuseofSida'sCash_ContributiontotheEDCTPS2906783_1_1.pdf",{"title":276,"category":279,"url":280,"format":267},{"narrative":277},{"lang":209,"value":278},"Beslut om ändring av insats European and Developing Countries Clinical Trials Partnership 2 (EDCTP2)",{"code":265},"https:\u002F\u002Fdocuments.iati.openaid.se\u002Fdocument\u002Fforsk\u002F54100039_040495-20Beslutomandringavinsats,EDCTP2_European-DevCountriesClinicalTrialsPa2808767_1_1.pdf",{"title":282,"category":285,"url":286,"format":267},{"narrative":283},{"lang":209,"value":284},"Avtal insats European and Developing Countries Clinical Trials Partnership 2 (EDCTP2)",{"code":273},"https:\u002F\u002Fdocuments.iati.openaid.se\u002Fdocument\u002Fforsk\u002F54100039_047203-15GrantagreementfortheuseofSidascashcontributiontotheEDCTPsecretariat1754307_1_1.pdf",{"title":288,"category":291,"url":292,"format":267},{"narrative":289},{"lang":209,"value":290},"Ändring avtal insats European and Developing Countries Clinical Trials Partnership 2 (EDCTP2) 2020_3",{"code":273},"https:\u002F\u002Fdocuments.iati.openaid.se\u002Fdocument\u002Fforsk\u002F54100039_041561-20RequestforfundingandAmendmenttotheagreementontheuseofSida'scashcon2813693_1_1.pdf",{"title":294,"category":297,"url":298,"format":267},{"narrative":295},{"lang":209,"value":296},"Beslut om insats European and Developing Countries Clinical Trials Partnership 2 (EDCTP2)",{"code":265},"https:\u002F\u002Fdocuments.iati.openaid.se\u002Fdocument\u002Fforsk\u002F54100039_044880-15Beslutominsats,EDCTP2_EuropeanandDevelopingCountriesClinicalTrialsPart1718343_1_1.pdf",{"title":300,"category":302,"url":303,"format":267},{"narrative":301},{"lang":209,"value":278},{"code":265},"https:\u002F\u002Fdocuments.iati.openaid.se\u002Fdocument\u002Fforsk\u002F54100039_017172-20BeslutomandringavinsatsEDCTP2_European-Dev2689696_1_1.pdf",{"title":305,"category":308,"url":309,"format":267},{"narrative":306},{"lang":209,"value":307},"Ändring avtal insats European and Developing Countries Clinical Trials Partnership 2 (EDCTP2) 2020_2",{"code":273},"https:\u002F\u002Fdocuments.iati.openaid.se\u002Fdocument\u002Fforsk\u002F54100039_019264-20AvtalsandringEDCTP2,(54100039)2699410_1_1.pdf",{"title":311,"category":313,"url":314,"format":267},{"narrative":312},{"lang":209,"value":278},{"code":265},"https:\u002F\u002Fdocuments.iati.openaid.se\u002Fdocument\u002Fforsk\u002F54100039_007003-20BeslutomandringavinsatsEDCTP2_European-Dev2632361_1_1.pdf",{"title":316,"category":319,"url":320,"format":267},{"narrative":317},{"lang":209,"value":318},"Ändring avtal insats European and Developing Countries Clinical Trials Partnership 2 (EDCTP2) 2020_1",{"code":273},"https:\u002F\u002Fdocuments.iati.openaid.se\u002Fdocument\u002Fforsk\u002F54100039_008722-20AmendmenttotheAgreementontheuseofSida'sCash_ContributiontotheEDCTPS2645574_1_1.pdf",{"title":322,"description":327,"indicator":330,"type":224,"aggregationstatus":206},[323,325],{"value":324},"Results achieved",{"lang":209,"value":326},"Uppnådda resultat",[328],{"value":329},"The EDCTP2 programme is in its completion phase, no new annual work plan or new calls have been published and the EDCTP Secretariat has focused on reviewing periodic and final reports, tracking the progress of projects, collecting outputs, and managing project closures.\n\nAs previously reported, the EDCTP2 programme was planned to run until the end of 2024, but due to the COVID-19 pandemic, the end of the programme has been extended until the end of 2026 to allow completion of all project grants (no-cost extensions of project duration). Likewise, Sida has extended the end date of the activity period of the agreement with the EDCTP Association until the end of 2026.\n\nExamples of project results\n\nThe EDCTP2 programme has adhered to its strategic vision and continues to deliver significant impact on poverty-related diseases and clinical research capacity in sub-Saharan Africa. Out of 48 projects supported by Sida, 33 were closed and 14 had reached their end date with final payments and reporting pending in the end of 2025. One project was still ongoing with an expected end date in March 2026.\n\nResearch area: Vaccine and neutralising antibody development for disease prevention\n\nPrevention of diarrhoeal disease in children:\n\nDiarrhoeal diseases continue to pose a serious threat to children in low- and middle-income countries. A leading cause of diarrhoea is enterotoxigenic E. coli (ETEC), a gut bacterium that can quickly lead to dehydration and require hospitalisation. Beyond the immediate dehydration risk, repeated bouts of diarrhoea can slow childrens growth, hinder learning, and limit future opportunities.\n\nSida is contributing to two projects on a vaccine (ETVAX) developed by the Swedish biopharma company Scandinavian Biopharma Holding AB against diarrheal disease caused by ETEC. A phase IIb clinical trial in infants aged 6 to 18 months in The Gambia demonstrated that ETVAX is safe and immunogenic and offers protection against ETEC, when considering all co-infections. A reduction of all-cause moderate-to-severe diarrhoea was observed, suggesting a broader public health benefit. The results of the study were published in The Lancet Infectious Diseases (doi: 10.1016\u002FS1473-3099(25)00774-1) and the European Medicines Agency reviewed the trials data and agreed that the vaccine candidate is ready to move forward to a pivotal phase III clinical trial. The consortium is currently seeking funding to carry out the phase III trial.\n\nResearch area: Drugs for treatment and prevention\n\nMalaria treatment:\n\nThe Sida-supported PAMAfrica consortium is conducting clinical trials to develop next-generation malaria treatments for Africa. There is currently no evidence-based treatment for babies weighing less than 5 kg with malaria. In April 2024, the PAMAfrica consortium announced positive results from their phase II\u002FIII CALINA study demonstrating that a new dose regimen of an existing treatment has good efficacy and safety for the smallest babies with malaria. The treatment called Coartem Baby was granted authorisation by the Swiss Agency for Therapeutic Products under the Marketing Authorisation for Global Health Products procedure in July 2025, and received World Health Organization (WHO) prequalification in April 2026. WHO prequalification ensures that the treatment meets international standards of quality, safety and efficacy and will enable global health procurers to include the treatment in their programmes and facilitate broader access to this vulnerable population. Coartem Baby is the first and only antimalarial developed specifically for newborns and young infants weighing from 2 to 5 kg and the prequalification of the treatment marks a major milestone in closing a long-standing treatment gap affecting some 30 million babies born each year in malaria-endemic areas of Africa.\n\nIn addition to the clinical study work, the PAMAfrica consortium has contributed to research capacity strengthening and training in a number of relevant areas including good clinical practice, health research ethics, scientific writing and communication skills.\n\nPublications\n\nIn the end of 2025, the EDCTP Secretariat recorded more than 500 scientific publications associated with Sida-funded projects (out of more than 2500 publications from all projects under the EDCTP2 programme). The majority of publications are related to projects in the emerging diseases area (56%), highlighting Sida's substantial contributions to research in this area, followed by HIV and HIV-associated infections (17%), malaria (10%), capacity building and training (6%), tuberculosis (4,5%), diarrhoeal diseases (3%), neglected infectious diseases (3%) and lower respiratory tract infections (0,5%).\n\nClinical research\n\nSida funds have supported 86 clinical studies being conducted on EDCTP projects of which 59% were clinical trials and interventional studies, i.e. studies of drugs, vaccines and broadly neutralising antibodies as well as diagnostics trials. The remaining studies were observational studies including cohort and epidemiological studies. Of the clinical trials, the majority evaluated the safety and efficacy of new of improved medical interventions (phase II\u002FIII trials) reflecting the intention set out in the EDCTP Strategic Business Plan to support the most critical phases of clinical development.\n\nImportantly, the EDCTP2 programme has succeeded in focusing on studies involving populations that are often excluded from clinical research but that have major unmet medical needs. 54% of the clinical studies supported by Sida involved populations with unmet medical needs including pregnant and lactating women and their children, newborns and infants, children as well as adolescents.\n\nIndividual research capacity strengthening\n\nSida-funding has provided training opportunities for 221 sub-Saharan African researchers (47% female, 53% male) at Bachelor, Master, PhD and postdoctoral level. 67% of the trainees are undertaking their training at an institution in sub-Saharan Africa.",{"title":331,"description":333,"measure":335,"ascending":206},{"narrative":332},"Not applicable",{"narrative":334},"No indicator available - only a description of the activity results is published",5,[337],{"ref":338,"type":224},"SE-0-SE-6-54100039-5410003901","2026-11-11T04:29:29+00:00","en","SEK",[343,363,368,373,379,384,388,394,399,404],{"accountableOrganisation":344,"thematicAreas":345,"code":231,"agency":230,"aidType":347,"collaborationType":219,"sector":255,"sectorCategory":348,"humanitarian":12,"sdgs":349,"sdgCategories":357,"activity":338,"year":359,"value":360,"recipient":250,"strategy":361,"strategyEndDate":362,"organisation":344},"47000:edctp\u002Feuropean_&_developing_countries_clinical_trials_partnership",[346],"other","B03",120,[350,351,352,353,354,355,356],"3.1","3.2","3.3","3.8","3.b","3.c","3.d",[358],"3.0",2015,25000000,1140102,"2022-09-30T00:00:00",{"accountableOrganisation":344,"thematicAreas":364,"code":231,"agency":230,"aidType":347,"collaborationType":219,"sector":255,"sectorCategory":348,"humanitarian":12,"sdgs":365,"sdgCategories":366,"activity":338,"year":367,"value":360,"recipient":250,"strategy":361,"strategyEndDate":362,"organisation":344},[346],[350,351,352,353,354,355,356],[358],2016,{"accountableOrganisation":344,"thematicAreas":369,"code":231,"agency":230,"aidType":347,"collaborationType":219,"sector":255,"sectorCategory":348,"humanitarian":12,"sdgs":370,"sdgCategories":371,"activity":338,"year":367,"value":372,"recipient":250,"strategy":361,"strategyEndDate":362,"organisation":344},[346],[350,351,352,353,354,355,356],[358],12500000,{"accountableOrganisation":344,"thematicAreas":374,"code":231,"agency":230,"aidType":347,"collaborationType":219,"sector":255,"sectorCategory":348,"humanitarian":12,"sdgs":375,"sdgCategories":376,"activity":338,"year":377,"value":378,"recipient":250,"strategy":361,"strategyEndDate":362,"organisation":344},[346],[350,351,352,353,354,355,356],[358],2017,37500000,{"accountableOrganisation":344,"thematicAreas":380,"code":231,"agency":230,"aidType":347,"collaborationType":219,"sector":255,"sectorCategory":348,"humanitarian":12,"sdgs":381,"sdgCategories":382,"activity":338,"year":383,"value":372,"recipient":250,"strategy":361,"strategyEndDate":362,"organisation":344},[346],[350,351,352,353,354,355,356],[358],2019,{"accountableOrganisation":344,"thematicAreas":385,"code":231,"agency":230,"aidType":347,"collaborationType":219,"sector":255,"sectorCategory":348,"humanitarian":12,"sdgs":386,"sdgCategories":387,"activity":338,"year":383,"value":372,"recipient":250,"strategy":361,"strategyEndDate":362,"organisation":344},[346],[350,351,352,353,354,355,356],[358],{"accountableOrganisation":344,"thematicAreas":389,"code":231,"agency":230,"aidType":347,"collaborationType":219,"sector":255,"sectorCategory":348,"humanitarian":12,"sdgs":390,"sdgCategories":391,"activity":338,"year":392,"value":393,"recipient":250,"strategy":361,"strategyEndDate":362,"organisation":344},[346],[350,351,352,353,354,355,356],[358],2020,21300000,{"accountableOrganisation":344,"thematicAreas":395,"code":231,"agency":230,"aidType":347,"collaborationType":219,"sector":255,"sectorCategory":348,"humanitarian":12,"sdgs":396,"sdgCategories":397,"activity":338,"year":392,"value":398,"recipient":250,"strategy":361,"strategyEndDate":362,"organisation":344},[346],[350,351,352,353,354,355,356],[358],9000000,{"accountableOrganisation":344,"thematicAreas":400,"code":231,"agency":230,"aidType":347,"collaborationType":219,"sector":255,"sectorCategory":348,"humanitarian":12,"sdgs":401,"sdgCategories":402,"activity":338,"year":392,"value":403,"recipient":250,"strategy":361,"strategyEndDate":362,"organisation":344},[346],[350,351,352,353,354,355,356],[358],2000000,{"accountableOrganisation":344,"thematicAreas":405,"code":231,"agency":230,"aidType":347,"collaborationType":219,"sector":255,"sectorCategory":348,"humanitarian":12,"sdgs":406,"sdgCategories":407,"activity":338,"year":408,"value":409,"recipient":250,"strategy":361,"strategyEndDate":362,"organisation":344},[346],[350,351,352,353,354,355,356],[358],2021,27675000,{"organisations":411},[412],{"role":413,"id":344,"name":414},4,"EDCTP\u002FEuropean & Developing Countries Clinical Trials Partnership",[416],{"iatiidentifier":338,"reportingorg":417,"title":418,"descriptions":422,"participatingorgs":430,"activitystatus":437,"activitydates":438,"tags":442,"policymarkers":485,"collaborationtype":508,"defaultfinancetype":509,"defaultaidtype":511,"defaulttiedstatus":512,"budgets":513,"planneddisbursements":575,"transactions":693,"relatedActivities":790,"strategies":792,"lastupdateddatetime":339,"lang":340,"defaultcurrency":341,"hierarchy":224,"humanitarian":206,"humanitarianSpecified":72},{"narrative":203,"ref":204,"type":205,"secondaryreporter":206},[419,420],{"lang":209,"value":210},{"value":421},"EDCTP2: European & Dev. Countries Clinical Trials Partnership 2015 - 2026 - EDCTP2 2015-2026",[423,427],{"narrative":424,"type":219},[425,426],{"value":216},{"lang":209,"value":218},{"narrative":428,"type":224},[429],{"value":223},[431,432,435,436],{"narrative":203,"ref":204,"crsChannelCode":227,"type":205,"typeSpecified":72,"role":219},{"narrative":414,"crsChannelCode":433,"type":434,"typeSpecified":72,"role":224},"47000",40,{"narrative":229,"ref":230,"crsChannelCode":227,"type":205,"typeSpecified":72,"role":231},{"narrative":414,"crsChannelCode":433,"type":434,"typeSpecified":72,"role":413},{"code":224},[439,440,441],{"type":224,"isodate":235},{"type":231,"isodate":237},{"type":219,"isodate":235},[443,449,455,461,467,473,479],{"narrative":444,"code":350,"vocabulary":231},[445,447],{"lang":209,"value":446},"3.1 - Till 2030 minska mödradödligheten i världen till mindre än 70 dödsfall per 100 000 förlossningar med levande barn.",{"value":448},"3.1 - By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births.",{"narrative":450,"code":351,"vocabulary":231},[451,453],{"value":452},"3.2 - By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under-5 mortality to at least as low as 25 per 1,000 live births.",{"lang":209,"value":454},"3.2 - Senast 2030 säkerställa att inga spädbarn eller barn under fem år dör av orsaker som hade kunnat förebyggas. Alla länder bör sträva efter att minska den neonatala dödligheten till högst tolv dödsfall per 1 000 levande födda och dödligheten bland barn under fem år till högst 25 dödsfall per 1 000 levande födda.",{"narrative":456,"code":352,"vocabulary":231},[457,459],{"value":458},"3.3 - By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases.",{"lang":209,"value":460},"3.3 - Senast 2030 utrota epidemierna av aids, tuberkulos, malaria och försummade tropiska sjukdomar samt bekämpa hepatit, vattenburna sjukdomar och andra smittsamma sjukdomar.",{"narrative":462,"code":353,"vocabulary":231},[463,465],{"value":464},"3.8 - Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all.",{"lang":209,"value":466},"3.8 - Åstadkomma allmän hälso- och sjukvård för alla, som även skyddar mot ekonomisk risk, tillgång till grundläggande hälso- och sjukvård av god kvalitet liksom tillgång till säkra, effektiva och ekonomiskt överkomliga grundläggande läkemedel och vaccin av god kvalitet.",{"narrative":468,"code":354,"vocabulary":231},[469,471],{"lang":209,"value":470},"3.b - Stödja forskning om och utveckling av vaccin och läkemedel mot de smittsamma och icke-smittsamma sjukdomar som i första hand drabbar utvecklingsländer. Sörja för tillgång till ekonomiskt överkomliga grundläggande läkemedel och vaccin, i enlighet med Doha-deklarationen om TRIPS-avtalet och folkhälsa, i vilken det bekräftas att utvecklingsländerna har rätt att fullt ut utnyttja den flexibilitet som avtalet om handelsrelaterade aspekter av immaterialrätter erbjuder för att skydda folkhälsan och, framför ",{"value":472},"3.b - Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public healt",{"narrative":474,"code":355,"vocabulary":231},[475,477],{"lang":209,"value":476},"3.c - Väsentligt stärka finansieringen av hälso- och sjukvården liksom insatserna för att rekrytera, utveckla, utbilda och behålla hälso- och sjukvårdspersonal i utvecklingsländerna, särskilt i de minst utvecklade länderna och små önationer under utveckling.",{"value":478},"3.c - Substantially increase health financing and the recruitment, development, training and retention of the health workforce in developing countries, especially in least developed countries and small island developing States.",{"narrative":480,"code":356,"vocabulary":231},[481,483],{"value":482},"3.d - Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks.",{"lang":209,"value":484},"3.d - Stärka alla länders, i synnerhet utvecklingsländernas, kapacitet när det gäller tidig varning, riskreducering och hantering av nationella och globala hälsorisker.",[486,488,490,492,494,497,500,503,505],{"narrative":487,"code":219,"vocabulary":219,"significance":206},"Gender Equality",{"narrative":489,"code":224,"vocabulary":219,"significance":206},"Aid to Environment",{"narrative":491,"code":413,"vocabulary":219,"significance":206},"Trade Development",{"narrative":493,"code":335,"vocabulary":219,"significance":206},"Aid Targeting the Objectives of the Convention on Biological Diversity",{"narrative":495,"code":496,"vocabulary":219,"significance":206},"Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation",6,{"narrative":498,"code":499,"vocabulary":219,"significance":206},"Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation",7,{"narrative":501,"code":502,"vocabulary":219,"significance":206},"Aid Targeting the Objectives of the Convention to Combat Desertification",8,{"narrative":504,"code":205,"vocabulary":219,"significance":206},"Disaster Risk Reduction(DRR)",{"narrative":506,"code":507,"vocabulary":219,"significance":206},"Disability",11,{"code":219},{"code":510},110,{"code":347},{"code":335},[514,520,526,532,538,544,550,556,562,569],{"periodstart":515,"periodend":517,"value":519},{"isodate":516},"2012-01-01T00:00:00",{"isodate":518},"2012-12-28T00:00:00",{"valuedate":516,"value":206},{"periodstart":521,"periodend":523,"value":525},{"isodate":522},"2013-01-01T00:00:00",{"isodate":524},"2013-12-28T00:00:00",{"valuedate":522,"value":206},{"periodstart":527,"periodend":529,"value":531},{"isodate":528},"2014-01-01T00:00:00",{"isodate":530},"2014-12-28T00:00:00",{"valuedate":528,"value":206},{"periodstart":533,"periodend":535,"value":537},{"isodate":534},"2015-01-01T00:00:00",{"isodate":536},"2015-12-28T00:00:00",{"valuedate":534,"value":360},{"periodstart":539,"periodend":541,"value":543},{"isodate":540},"2016-01-01T00:00:00",{"isodate":542},"2016-12-28T00:00:00",{"valuedate":540,"value":378},{"periodstart":545,"periodend":547,"value":549},{"isodate":546},"2017-01-01T00:00:00",{"isodate":548},"2017-12-28T00:00:00",{"valuedate":546,"value":378},{"periodstart":551,"periodend":553,"value":555},{"isodate":552},"2018-01-01T00:00:00",{"isodate":554},"2018-12-28T00:00:00",{"valuedate":552,"value":206},{"periodstart":557,"periodend":559,"value":561},{"isodate":558},"2019-01-01T00:00:00",{"isodate":560},"2019-12-28T00:00:00",{"valuedate":558,"value":360},{"periodstart":563,"periodend":565,"value":567},{"isodate":564},"2020-01-01T00:00:00",{"isodate":566},"2020-12-28T00:00:00",{"valuedate":564,"value":568},32300000,{"periodstart":570,"periodend":572,"value":574},{"isodate":571},"2021-01-01T00:00:00",{"isodate":573},"2021-12-28T00:00:00",{"valuedate":571,"value":409},[576,581,586,591,596,601,606,611,616,621,626,632,637,642,647,652,658,663,668,673,678,683,688],{"periodstart":577,"periodend":578,"value":579},{"isodate":522},{"isodate":524},{"valuedate":580,"value":206},"2013-12-31T00:00:00",{"periodstart":582,"periodend":583,"value":584},{"isodate":546},{"isodate":548},{"valuedate":585,"value":360},"2017-12-31T00:00:00",{"periodstart":587,"periodend":588,"value":589},{"isodate":534},{"isodate":536},{"valuedate":590,"value":360},"2015-12-31T00:00:00",{"periodstart":592,"periodend":593,"value":594},{"isodate":516},{"isodate":518},{"valuedate":595,"value":206},"2012-12-31T00:00:00",{"periodstart":597,"periodend":598,"value":599},{"isodate":546},{"isodate":548},{"valuedate":600,"value":206},"2017-09-01T00:00:00",{"periodstart":602,"periodend":603,"value":604},{"isodate":558},{"isodate":560},{"valuedate":605,"value":206},"2019-06-01T00:00:00",{"periodstart":607,"periodend":608,"value":609},{"isodate":528},{"isodate":530},{"valuedate":610,"value":206},"2014-12-31T00:00:00",{"periodstart":612,"periodend":613,"value":614},{"isodate":540},{"isodate":542},{"valuedate":615,"value":360},"2016-10-01T00:00:00",{"periodstart":617,"periodend":618,"value":619},{"isodate":540},{"isodate":542},{"valuedate":620,"value":360},"2016-12-31T00:00:00",{"periodstart":622,"periodend":623,"value":624},{"isodate":564},{"isodate":566},{"valuedate":625,"value":393},"2020-03-01T00:00:00",{"periodstart":627,"periodend":628,"value":629},{"isodate":552},{"isodate":554},{"valuedate":630,"value":631},"2018-12-01T00:00:00",-25000000,{"periodstart":633,"periodend":634,"value":635},{"isodate":552},{"isodate":554},{"valuedate":636,"value":360},"2018-12-31T00:00:00",{"periodstart":638,"periodend":639,"value":640},{"isodate":564},{"isodate":566},{"valuedate":641,"value":398},"2020-11-01T00:00:00",{"periodstart":643,"periodend":644,"value":645},{"isodate":558},{"isodate":560},{"valuedate":646,"value":631},"2019-12-01T00:00:00",{"periodstart":648,"periodend":649,"value":650},{"isodate":546},{"isodate":548},{"valuedate":651,"value":372},"2017-12-01T00:00:00",{"periodstart":653,"periodend":654,"value":655},{"isodate":540},{"isodate":542},{"valuedate":656,"value":657},"2016-12-01T00:00:00",-12500000,{"periodstart":659,"periodend":660,"value":661},{"isodate":552},{"isodate":554},{"valuedate":662,"value":206},"2018-02-01T00:00:00",{"periodstart":664,"periodend":665,"value":666},{"isodate":558},{"isodate":560},{"valuedate":667,"value":372},"2019-05-01T00:00:00",{"periodstart":669,"periodend":670,"value":671},{"isodate":564},{"isodate":566},{"valuedate":672,"value":206},"2020-10-01T00:00:00",{"periodstart":674,"periodend":675,"value":676},{"isodate":558},{"isodate":560},{"valuedate":677,"value":360},"2019-12-31T00:00:00",{"periodstart":679,"periodend":680,"value":681},{"isodate":558},{"isodate":560},{"valuedate":682,"value":372},"2019-09-01T00:00:00",{"periodstart":684,"periodend":685,"value":686},{"isodate":564},{"isodate":566},{"valuedate":687,"value":403},"2020-12-01T00:00:00",{"periodstart":689,"periodend":690,"value":691},{"isodate":571},{"isodate":573},{"valuedate":692,"value":409},"2021-05-01T00:00:00",[694,704,712,721,729,737,746,755,764,773,781],{"transactiontype":695,"transactiondate":696,"value":697,"sector":699,"recipientregion":702},{"code":224},{"isodate":235},{"valuedate":235,"value":698},184975000,[700,701],{"vocabulary":224,"code":258},{"vocabulary":219,"code":255},{"code":703},298,{"transactiontype":705,"transactiondate":706,"value":707,"sector":708,"recipientregion":711},{"code":231},{"isodate":536},{"valuedate":536,"value":360},[709,710],{"vocabulary":224,"code":258},{"vocabulary":219,"code":255},{"code":703},{"transactiontype":713,"transactiondate":714,"value":716,"sector":717,"recipientregion":720},{"code":231},{"isodate":715},"2016-10-28T00:00:00",{"valuedate":715,"value":360},[718,719],{"vocabulary":224,"code":258},{"vocabulary":219,"code":255},{"code":703},{"transactiontype":722,"transactiondate":723,"value":724,"sector":725,"recipientregion":728},{"code":231},{"isodate":542},{"valuedate":542,"value":372},[726,727],{"vocabulary":224,"code":258},{"vocabulary":219,"code":255},{"code":703},{"transactiontype":730,"transactiondate":731,"value":732,"sector":733,"recipientregion":736},{"code":231},{"isodate":548},{"valuedate":548,"value":378},[734,735],{"vocabulary":224,"code":258},{"vocabulary":219,"code":255},{"code":703},{"transactiontype":738,"transactiondate":739,"value":741,"sector":742,"recipientregion":745},{"code":231},{"isodate":740},"2019-05-28T00:00:00",{"valuedate":740,"value":372},[743,744],{"vocabulary":224,"code":258},{"vocabulary":219,"code":255},{"code":703},{"transactiontype":747,"transactiondate":748,"value":750,"sector":751,"recipientregion":754},{"code":231},{"isodate":749},"2019-09-28T00:00:00",{"valuedate":749,"value":372},[752,753],{"vocabulary":224,"code":258},{"vocabulary":219,"code":255},{"code":703},{"transactiontype":756,"transactiondate":757,"value":759,"sector":760,"recipientregion":763},{"code":231},{"isodate":758},"2020-03-28T00:00:00",{"valuedate":758,"value":393},[761,762],{"vocabulary":224,"code":258},{"vocabulary":219,"code":255},{"code":703},{"transactiontype":765,"transactiondate":766,"value":768,"sector":769,"recipientregion":772},{"code":231},{"isodate":767},"2020-11-28T00:00:00",{"valuedate":767,"value":398},[770,771],{"vocabulary":224,"code":258},{"vocabulary":219,"code":255},{"code":703},{"transactiontype":774,"transactiondate":775,"value":776,"sector":777,"recipientregion":780},{"code":231},{"isodate":566},{"valuedate":566,"value":403},[778,779],{"vocabulary":224,"code":258},{"vocabulary":219,"code":255},{"code":703},{"transactiontype":782,"transactiondate":783,"value":785,"sector":786,"recipientregion":789},{"code":231},{"isodate":784},"2021-05-28T00:00:00",{"valuedate":784,"value":409},[787,788],{"vocabulary":224,"code":258},{"vocabulary":219,"code":255},{"code":703},[791],{"ref":201,"type":219},{"strategy":793},{"title":794,"strategyObjective":799,"code":361,"strategystartdate":534,"strategyenddate":362,"strategyamount":206,"currency":341},[795,797],{"value":796},"Research cooperation 2015-2022",{"lang":209,"value":798},"Forskningssamarbete 2015-2022",[800,814,826],{"name":801,"thematicArea":806,"code":812,"percentage":813},[802,804],{"value":803},"More partner countries have capacity to independently undertake research training and conduct high-quality research",{"lang":209,"value":805},"Fler samarbetsländer har kapacitet att självständigt genomföra forskarutbildningar och bedriva forskning av hög kvalitet",{"narrative":807},[808,810],{"value":809},"Other",{"lang":209,"value":811},"Övrigt","FORSK20152021a1",25,{"name":815,"thematicArea":820,"code":824,"percentage":825},[816,818],{"value":817},"Findings from relevant international research have a greater impact on national and regional research",{"lang":209,"value":819},"Resultat från relevant internationell forskning får ökat genomslag i nationell och regional forskning",{"narrative":821},[822,823],{"value":809},{"lang":209,"value":811},"FORSK20152021b3",60,{"name":827,"thematicArea":832,"code":836,"percentage":837},[828,830],{"value":829},"Improved conditions for researchers to develop innovative ideas with the potential to contribute to the emergence of new products and services that contribute to poverty reduction and a sustainable society",{"lang":209,"value":831},"Förbättrade förutsättningar för forskare att utveckla innovativa idéer med potential att bidra till framväxandet av nya produkter och tjänster som bidrar till minskad fattigdom och ett hållbart samhälle",{"narrative":833},[834,835],{"value":809},{"lang":209,"value":811},"FORSK20152021c2",15,[839,841,843,845,847,849,851,853,855,857],{"type":231,"transactionDate":359,"valueDate":840,"value":360,"recipientcountry":140,"recipientregion":711,"sector":708},["Date","2015-12-27T23:00:00.000Z"],{"type":231,"transactionDate":367,"valueDate":842,"value":360,"recipientcountry":140,"recipientregion":720,"sector":717},["Date","2016-10-27T22:00:00.000Z"],{"type":231,"transactionDate":367,"valueDate":844,"value":372,"recipientcountry":140,"recipientregion":728,"sector":725},["Date","2016-12-27T23:00:00.000Z"],{"type":231,"transactionDate":377,"valueDate":846,"value":378,"recipientcountry":140,"recipientregion":736,"sector":733},["Date","2017-12-27T23:00:00.000Z"],{"type":231,"transactionDate":383,"valueDate":848,"value":372,"recipientcountry":140,"recipientregion":745,"sector":742},["Date","2019-05-27T22:00:00.000Z"],{"type":231,"transactionDate":383,"valueDate":850,"value":372,"recipientcountry":140,"recipientregion":754,"sector":751},["Date","2019-09-27T22:00:00.000Z"],{"type":231,"transactionDate":392,"valueDate":852,"value":393,"recipientcountry":140,"recipientregion":763,"sector":760},["Date","2020-03-27T23:00:00.000Z"],{"type":231,"transactionDate":392,"valueDate":854,"value":398,"recipientcountry":140,"recipientregion":772,"sector":769},["Date","2020-11-27T23:00:00.000Z"],{"type":231,"transactionDate":392,"valueDate":856,"value":403,"recipientcountry":140,"recipientregion":780,"sector":777},["Date","2020-12-27T23:00:00.000Z"],{"type":231,"transactionDate":408,"valueDate":858,"value":409,"recipientcountry":140,"recipientregion":789,"sector":786},["Date","2021-05-27T22:00:00.000Z"],[860,839,841,843,845,847,849,851,853,855,857],{"type":224,"transactionDate":359,"valueDate":861,"value":698,"recipientcountry":140,"recipientregion":702,"sector":699},["Date","2015-11-30T23:00:00.000Z"],[793],{"links":864,"preamble":918,"dateObject":921},[865,873,882,891,900,909],{"id":866,"title":867,"slug":870,"post_id":813,"children":140,"description":140,"description_title":140,"description_swe":140,"description_title_swe":140,"localization":871},216,{"en":868,"sv":869},"About Openaid","Om Openaid","about-openaid",{"sv_slug":872},"om-openaid",{"id":874,"title":875,"slug":878,"post_id":879,"children":140,"description":140,"description_title":140,"description_swe":140,"description_title_swe":140,"localization":880},9424,{"en":876,"sv":877},"Contacts","Kontakt","about-openaid\u002Fcontact",49,{"sv_slug":881},"om-openaid\u002Fkontakt",{"id":883,"title":884,"slug":887,"post_id":888,"children":140,"description":140,"description_title":140,"description_swe":140,"description_title_swe":140,"localization":889},221,{"en":885,"sv":886},"Publications","Publikationer","about-openaid\u002Fpublications",158,{"sv_slug":890},"om-openaid\u002Fpublikationer",{"id":892,"title":893,"slug":896,"post_id":897,"children":140,"description":140,"description_title":140,"description_swe":140,"description_title_swe":140,"localization":898},217,{"en":894,"sv":895},"Accessibility of Openaid","Tillgänglighetsredogörelse","about-openaid\u002Faccessibility-of-openaid",156,{"sv_slug":899},"om-openaid\u002Ftillganglighetsredogorelse",{"id":901,"title":902,"slug":905,"post_id":906,"children":140,"description":140,"description_title":140,"description_swe":140,"description_title_swe":140,"localization":907},220,{"en":903,"sv":904},"Privacy notice","Behandling av personuppgifter","about-openaid\u002Fprivacy-notice",42,{"sv_slug":908},"om-openaid\u002Fbehandling-av-personuppgifter",{"id":910,"title":911,"slug":914,"post_id":915,"children":140,"description":140,"description_title":140,"description_swe":140,"description_title_swe":140,"localization":916},222,{"en":912,"sv":913},"Report suspicions of corruption, irregularities, and misconduct","Anmäl misstankar om korruption","about-openaid\u002Freport-suspicions-of-corruption-irregularities-and-misconduct",47,{"sv_slug":917},"om-openaid\u002Fanmal-misstankar-om-korruption-oegentligheter-och-missforhallanden",{"en":919,"sv":920},"Openaid publishes information from agencies and departments in accordance with the transparency guarantee.","På Openaid publiceras information från myndigheter och departement i enlighet med transparensgarantin.",{"lastImport":922,"generatedDate":923},"2026-11-11T07:25:00.211818","2026-11-11T04:29:23+00:00"]